Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-2-13
pubmed:abstractText
Hepatic steatosis often is observed in patients with chronic hepatitis C and has been reported to be associated with hepatic fibrosis and impaired treatment response in some studies. Our aim was to determine the prevalence of and risk factors for hepatic steatosis among Hepatitis C Antiviral Long-term Treatment against Cirrhosis patients, and to determine the relationship between steatosis, fibrosis, and sustained virologic response (SVR) to re-treatment with pegylated interferon and ribavirin.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00042, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00043, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00051, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00065, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00633, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00827, http://linkedlifedata.com/resource/pubmed/grant/M01RR-01066, http://linkedlifedata.com/resource/pubmed/grant/M01RR-06192, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2318, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2319, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2320, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2321, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2322, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2323, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2324, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2325, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2326, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2327, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2328, http://linkedlifedata.com/resource/pubmed/grant/P60 DK020572-28
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1542-7714
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
245-54
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17296533-Adult, pubmed-meshheading:17296533-Aged, pubmed-meshheading:17296533-Aged, 80 and over, pubmed-meshheading:17296533-Antiviral Agents, pubmed-meshheading:17296533-Diabetes Mellitus, pubmed-meshheading:17296533-Disease Progression, pubmed-meshheading:17296533-Fatty Liver, pubmed-meshheading:17296533-Female, pubmed-meshheading:17296533-Hepatitis C, pubmed-meshheading:17296533-Humans, pubmed-meshheading:17296533-Interferon-alpha, pubmed-meshheading:17296533-Liver Cirrhosis, pubmed-meshheading:17296533-Male, pubmed-meshheading:17296533-Middle Aged, pubmed-meshheading:17296533-Polyethylene Glycols, pubmed-meshheading:17296533-Prevalence, pubmed-meshheading:17296533-Prospective Studies, pubmed-meshheading:17296533-Recombinant Proteins, pubmed-meshheading:17296533-Ribavirin, pubmed-meshheading:17296533-Risk Factors
pubmed:year
2007
pubmed:articleTitle
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
pubmed:affiliation
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0362, USA. aslok@umich.edu
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Multicenter Study, Research Support, N.I.H., Extramural